Rosanne Terraciano Email

VP Operations . Vascular Therapies

Current Roles

Employees:
7
Revenue:
$703.5k
About
Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery. Sirogen™ is currently undergoing clinical trials to determine its safety and effectiveness in improving vascular access outcomes in patients requiring an arteriovenous fistula for hemodialysis.
Vascular Therapies Address
105 Union Avenue
Cresskill, NJ
Vascular Therapies Email

Past Companies

Vascular Therapies Inc.Vice President of Operations
Datascope (Collagen Products Division)Director, Worldwide Marketing
CORDIS CORPORATION, A JOHNSON AND JOHNSON COMPANYMarketing Manager

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.